Talius Group (ASX:TAL) has been selected by the Brisbane Economic Development Agency to participate in the MedTech global accelerator program for 2026, according to a Monday filing with the Australian bourse.
The program supports the launch of a funding campaign and fast-track connections with funders, licensing and distribution partners, the filing said.
Shares of the company rose 3% in recent Monday trade.